// App-Quantinova.ai

4050 : Prospective randomized phase II study of concurrent chemoradiotherapy versus chemotherapy alone in stage IV esophageal squamous cell carcinoma.

Researchers

Presenter

  • Tao Li

Principal Investigators

  • Jiahua Lv

  • Fang Li

  • Peng Diao

  • Junchao Wang

  • Rong Chu Li

  • Long Liang

  • Lei Sun

Medical Centers

  • Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Chengdu, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Esophageal squamous carcinoma cell

Biomarkers

  • N/A

Drug/Treatment

  • Docetaxel

  • Cisplatin

Outcome

  • N/A


Study Design

  • Randomized

  • Prospective

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final